Obacunone inhibits ferroptosis through regulation of Nrf2 homeostasis to treat diabetic nephropathy

Ou,Yi; Zhang,Wenjuan

doi:10.3892/mmr.2025.13500

Obacunone inhibits ferroptosis through regulation of Nrf2 homeostasis to treat diabetic nephropathy

Authors:
- Yi Ou
- Wenjuan Zhang
View Affiliations

Affiliations: Department of Endocrinology, Shenzhen Fuyong People's Hospital, Shenzhen, Guangdong 518100, P.R. China, Department of Public Health and Preventive Medicine, School of Basic Medicine, Jinan University, Guangzhou, Guangdong 510000, P.R. China
Published online on: March 19, 2025 https://doi.org/10.3892/mmr.2025.13500
Article Number: 135
Copyright: © Ou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic nephropathy (DN), a prevalent and severe microvascular complication of diabetes, often leads to end‑stage renal disease and poses a threat to patient survival. However, to the best of our knowledge, there are currently no effective strategies available for the treatment of DN. Obacunone (OB), a small‑molecule natural compound derived from Citrus plants, exhibits various pharmacological effects; however, the impact of OB on DN remains to be fully elucidated. Therefore, the present study aimed to explore the effects and potential mechanisms of OB in DN. In the current study, DN models were created in vitro by treating HK‑2 cells with high‑glucose (HG) levels, and in vivo by administering a HG and high‑fat diet along with intraperitoneal injections of streptozotocin to Sprague‑Dawley rats. Subsequently, cell viability was evaluated using the Cell Counting Kit‑8 assay, while ferroptosis‑related marker levels were determined using biochemical kits, immunofluorescence and western blotting. Activation and homeostasis of the nuclear factor erythroid 2‑related factor 2 (Nrf2) signaling pathway were analyzed using western blotting, co‑immunoprecipitation and reverse transcription‑quantitative PCR. In addition, alterations in renal function parameters and the severity of renal pathological injury in rats were examined. The in vitro experiments demonstrated that OB significantly promoted cell viability and inhibited ferroptosis, as evidenced by increased glutathione peroxidase 4 and SLC7A11 expression, and decreased levels of malondialdehyde, ferrous ion and reactive oxygen species (P<0.05). Additionally, OB activated the Nrf2 signaling pathway, blocked the interaction between Nrf2 and Kelch‑like ECH‑associated protein 1, and suppressed Nrf2 ubiquitination and degradation (P<0.05). In vivo, OB administration improved renal function parameters, including serum creatinine and blood urea nitrogen levels (P<0.05), and reduced renal pathological injury, in comparison with the DN group. The results of the present study indicated that OB, a natural small molecule, exhibited significant anti‑DN effects, possibly through the regulation of Nrf2 homeostasis to inhibit ferroptosis. Overall, this study provides new evidence for OB as a potential clinical treatment for DN.

View Figures

View References

1	Deng W, Zhao L, Chen C, Ren Z, Jing Y, Qiu J and Liu D: National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021. J Diabetes. 16:e700122024. View Article : Google Scholar : PubMed/NCBI
2	Qi C, Mao X, Zhang Z and Wu H: Classification and differential diagnosis of diabetic nephropathy. J Diabetes Res. 2017:86371382017. View Article : Google Scholar : PubMed/NCBI
3	Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP and Zierath JR: Exercise/physical activity in individuals with type 2 diabetes: A consensus statement from the American college of sports medicine. Med Sci Sports Exerc. 54:353–368. 2022. View Article : Google Scholar : PubMed/NCBI
4	Chen J, Liu Q, He J and Li Y: Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target. Front Immunol. 13:9587902022. View Article : Google Scholar : PubMed/NCBI
5	Zoja C, Xinaris C and Macconi D: Diabetic nephropathy: Novel molecular mechanisms and therapeutic targets. Front Pharmacol. 11:5868922020. View Article : Google Scholar : PubMed/NCBI
6	Naaman SC and Bakris GL: Diabetic nephropathy: Update on pillars of therapy slowing progression. Diabetes Care. 46:1574–1586. 2023. View Article : Google Scholar : PubMed/NCBI
7	Samsu N: Diabetic nephropathy: Challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021:14974492021. View Article : Google Scholar : PubMed/NCBI
8	Zhou TY, Tian N, Li L and Yu R: Iridoids modulate inflammation in diabetic kidney disease: A review. J Integr Med. 22:210–222. 2024. View Article : Google Scholar : PubMed/NCBI
9	Shinjyo N, Parkinson J, Bell J, Katsuno T and Bligh A: Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. J Integr Med. 18:125–151. 2020. View Article : Google Scholar : PubMed/NCBI
10	Zheng W, Yang S and Chen X: The pharmacological and pharmacokinetic properties of obacunone from citrus fruits: A comprehensive narrative review. Fitoterapia. 169:1055692023. View Article : Google Scholar : PubMed/NCBI
11	Wang S, Kuperman LL, Song Z, Chen Y, Liu K, Xia Z, Xu Y and Yu Q: An overview of limonoid synthetic derivatives as promising bioactive molecules. Eur J Med Chem. 259:1157042023. View Article : Google Scholar : PubMed/NCBI
12	Ono E, Inoue J, Hashidume T, Shimizu M and Sato R: Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet. Biochem Biophys Res Commun. 410:677–681. 2011. View Article : Google Scholar : PubMed/NCBI
13	Qiu Z, He J, Shao G, Hu J, Li X, Zhou H, Li M and Yang B: Obacunone retards renal cyst development in autosomal dominant polycystic kidney disease by activating NRF2. Antioxidants (Basel). 11:382021. View Article : Google Scholar : PubMed/NCBI
14	Kurosaki Y, Imoto A, Kawakami F, Ouchi M, Morita A, Yokoba M, Takenaka T, Ichikawa T, Katagiri M, Nielsen R and Ishii N: In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells. Mol Cell Biochem. 477:689–699. 2022. View Article : Google Scholar : PubMed/NCBI
15	Zhou J, Wang T, Wang H, Jiang Y and Peng S: Obacunone attenuates high glucose-induced oxidative damage in NRK-52E cells by inhibiting the activity of GSK-3beta. Biochem Biophys Res Commun. 513:226–233. 2019. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
17	Xue S, Li YX, Lu XX and Tang W: Dapagliflozin can alleviate renal fibrosis in rats with streptozotocin-induced type 2 diabetes mellitus. Exp Ther Med. 26:5722023. View Article : Google Scholar : PubMed/NCBI
18	Wahab NAA, Giribabu N, Kilari EK and Salleh N: Abietic acid ameliorates nephropathy progression via mitigating renal oxidative stress, inflammation, fibrosis and apoptosis in high fat diet and low dose streptozotocin-induced diabetic rats. Phytomedicine. 107:1544642022. View Article : Google Scholar : PubMed/NCBI
19	Lang X, Zhang X, Wang D and Zhou W: In vitro and in vivo metabolic activation of obacunone, a bioactive and potentially hepatotoxic constituent of dictamni cortex. Planta Med. 86:686–695. 2020. View Article : Google Scholar : PubMed/NCBI
20	AlTamimi JZ, AlFaris NA, Alshammari GM, Alagal RI, Aljabryn DH and Abdo Yahya M: Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2. Saudi Pharm J. 31:1018172023. View Article : Google Scholar : PubMed/NCBI
21	Fischer AH, Jacobson KA, Rose J and Zeller R: Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008.pdb prot4986. 2008.
22	Liu Y and Tang SC: Recent progress in stem cell therapy for diabetic nephropathy. Kidney Dis (Basel). 2:20–27. 2016. View Article : Google Scholar : PubMed/NCBI
23	Song X and Long D: Nrf2 and Ferroptosis: A new research direction for neurodegenerative diseases. Front Neurosci. 14:2672020. View Article : Google Scholar : PubMed/NCBI
24	Sharma K, McCue P and Dunn SR: Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol. 284:F1138–F1144. 2003. View Article : Google Scholar : PubMed/NCBI
25	Li Z, Lu S and Li X: The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury. Cell Mol Life Sci. 78:5731–5741. 2021. View Article : Google Scholar : PubMed/NCBI
26	Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 171:273–285. 2017. View Article : Google Scholar : PubMed/NCBI
27	Ding K, Liu C, Li L, Yang M, Jiang N, Luo S and Sun L: Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism. Chin Med J (Engl). 136:2521–2537. 2023.PubMed/NCBI
28	Mengstie MA, Seid MA, Gebeyehu NA, Adella GA, Kassie GA, Bayih WA, Gesese MM, Anley DT, Feleke SF, Zemene MA, et al: Ferroptosis in diabetic nephropathy: Mechanisms and therapeutic implications. Metabol Open. 18:1002432023. View Article : Google Scholar : PubMed/NCBI
29	Chen J, Ou Z, Gao T, Yang Y, Shu A, Xu H, Chen Y and Lv Z: Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy. Biomed Pharmacother. 156:1139532022. View Article : Google Scholar : PubMed/NCBI
30	Ajiboye BO, Famusiwa CD, Nifemi DM, Ayodele BM, Akinlolu OS, Fatoki TH, Ezzat AO, Al-Lohedan HA, Gupta S and Oyinloye BE: Nephroprotective effect of hibiscus sabdariffa leaf flavonoid extracts via KIM-1 and TGF-1beta signaling pathways in streptozotocin-induced rats. ACS Omega. 9:19334–19344. 2024. View Article : Google Scholar : PubMed/NCBI
31	Zhang W, Liu Y, Zhou J, Qiu T, Xie H and Pu Z: Chicoric acid advanced PAQR3 ubiquitination to ameliorate ferroptosis in diabetes nephropathy through the relieving of the interaction between PAQR3 and P110alpha pathway. Clin Exp Hypertens. 46:23260212024. View Article : Google Scholar : PubMed/NCBI
32	Jiang X, Stockwell BR and Conrad M: Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
33	Chen F, Xiao M, Hu S and Wang M: Keap1-Nrf2 pathway: A key mechanism in the occurrence and development of cancer. Front Oncol. 14:13814672024. View Article : Google Scholar : PubMed/NCBI
34	Nan F, Tian Q and Chen S: Obacunone alleviates inflammatory pain by promoting m2 microglial polarization and by activating Nrf2/HO-1 signaling pathway. Drug Des Devel Ther. 18:1265–1275. 2024. View Article : Google Scholar : PubMed/NCBI
35	Li J, Deng SH, Li J, Li L, Zhang F, Zou Y, Wu DM and Xu Y: Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses. Cell Mol Biol Lett. 27:292022. View Article : Google Scholar : PubMed/NCBI
36	Bai Y, Wang W, Wang L, Ma L, Zhai D, Wang F, Shi R, Liu C, Xu Q, Chen G and Lu Z: Obacunone attenuates liver fibrosis with enhancing anti-oxidant effects of GPx-4 and inhibition of EMT. Molecules. 26:3182021. View Article : Google Scholar : PubMed/NCBI
37	Anders HJ and Schlondorff D: Toll-like receptors: Emerging concepts in kidney disease. Curr Opin Nephrol Hypertens. 16:177–183. 2007. View Article : Google Scholar : PubMed/NCBI
38	Bonventre JV and Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 121:4210–4221. 2011. View Article : Google Scholar : PubMed/NCBI
39	Zhang X, Donnan PT, Bell S and Guthrie B: Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: Systematic review and meta-analysis. BMC Nephrol. 18:2562017. View Article : Google Scholar : PubMed/NCBI